TAMBE device post-marketing safety and effectiveness for thoracoabdominal and pararenal aortic aneurysms
Official title: GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis Post-Marketing Surveillance
Run by W.L.Gore & Associates · NCT07147569 · Data updated 2026-11-12
This tests whether the TAMBE multi-component device (GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis) is safe and works well for people treated for thoracoabdominal or pararenal aortic aneurysms in Japan.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | W.L.Gore & Associates Industry-sponsored |
| Locations | 5 sites (Minatoku and 4 other locations) |
| Status | Recruiting |
| Started | March 27, 2026 |
| Main results expected | February 28, 2034 |
| Study ends | February 28, 2034 |
| Registry record updated | May 5, 2026 |
| Trial ID | NCT07147569 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults in Japan with thoracoabdominal or pararenal aortic aneurysms who underwent an attempted implant of the AC component at a participating site.
✕Probably not a fit
Patients who were not offered or did not undergo an attempted AC implant, or whose anatomy or health status make branched endografting inappropriate, are unlikely to receive benefit from this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is an observational post-marketing surveillance program following patients in Japan who had an attempt to implant the GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis (Aortic Component, AC) for thoracoabdominal or pararenal abdominal aortic aneurysms. Participating centers collect real-world data on procedural details, device performance, adverse events, reinterventions, and imaging findings during routine follow-up. Data are reported to the sponsor to characterize safety signals and clinical outcomes in typical practice settings. The program aims to inform clinicians and regulators about device performance outside premarket trials.
Why it matters
Potential benefit: If successful, this could confirm that the TAMBE device is a durable endovascular option for complex aortic aneurysms and improve confidence in patient safety and treatment planning.
How similar studies have gone: Branched and fenestrated aortic endografts have shown promising outcomes in prior clinical experience, but specific post-marketing evidence for this TAMBE configuration remains limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients who were attempted to implant the AC * Thoracoabdominal aortic aneurysm * Pararenal abdominal aortic aneurysm Exclusion Criteria: * N/A
Where it's running
-
The Jikei University Hospital
Minatoku, Japan Recruiting -
Nagoya University Hospital
Nagoya, Japan Recruiting -
Morinomiya Hospital
Osaka, Japan Recruiting -
Osaka International Medical & Science Center Osaka Police Hospital
Osaka, Japan Recruiting -
The University of Osaka Hospital
Suita, Japan Recruiting
Study contacts
- Study coordinator: Katsuyuki Niwa
- Email: kniwa@wlgore.com
- Phone: +819017754499
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Modified endograft treatment for complex aortic aneurysms
This study is testing a special type of stent to see if it can safely treat complex aortic aneurysms in high-risk patients who can’t use regular devices.
-
Using modified endografts to treat complex aortic aneurysms
This study tests if specially modified stents can safely treat people with complex aortic aneurysms who can't have regular surgery.
-
Femorofemoral versus left‑heart bypass for open thoracoabdominal aortic aneurysm repair
This will test whether femorofemoral bypass or left‑heart bypass works better for adults having open repair of a thoracoabdominal aortic aneurysm.
-
Physician-modified endograft repair for complex abdominal and thoracoabdominal aortic aneurysms in high-risk patients
This study will try physician-modified endografts to repair complex abdominal and thoracoabdominal aortic aneurysms in patients who are too high-risk for open surgery and do not meet criteria for currently approved devices.
-
BAO-G technique for repairing complex thoracoabdominal and abdominal aortic aneurysms
This study will try the BAO-G endovascular technique, which uses off-the-shelf iliac branched devices to rebuild visceral branches in patients with complex thoracoabdominal or abdominal aortic aneurysms who are candidates for endovascular repair.
-
Evaluation of a 3D-Printed Stent-Graft for Aortic Aneurysms
This study is testing a new 3D-printed stent-graft to see if it works better and is safer than standard devices for treating complex abdominal aortic aneurysms in about 100 patients.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.